▲ Peaking
Health
Triple-dose regimen may permanently clear HIV in infected newborns
Early research indicates a new triple-dose regimen could permanently clear HIV in infected newborns.
Hiv
17 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
🔮 fades ✗
How poor countries are dealing with America’s AIDS cuts
Global health coverage examines how poor nations manage funding cuts following America's aid reset.
◼ Archived
Health
🔮 fades ✓
Brazil’s HIV advocates say they predicted USAID funding cuts: ‘We would see the trends’
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Finish the fight against HIV/AIDS
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
The HIV shot that could change medicine is facing its biggest test: Getting to patients
Long-acting lenacapavir shows effective HIV PrEP results after a year, raising urgent questions about patient access.
◼ Archived
Health
🔮 fades ✓
HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
#Aids2026: We analysed SA’s first LEN roll-out data. Here’s what we found
Analysis of South Africa's first Lenacapavir roll-out data emerges alongside global coverage of the twice-yearly HIV prevention shot.
◼ Archived
Health
🔮 fades ✗
New report reveals consequences of Trump administration's HIV/AIDS funding cuts
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
World risks HIV resurgence as funding falls 18%, UNAIDS says
UNAIDS warns of a potential global HIV resurgence following an 18% drop in funding for the international response.
◼ Archived
Business
🔮 fades
With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Merck is establishing global access and licensing frameworks for the world's first monthly oral HIV prevention pill ahead of its official approval.
◼ Archived
Health
🔮 fades
S.F. HIV groups ‘stunned’ by latest grant cuts after Trump vowed to ‘defeat AIDS’
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
Philly dental office reopens 2 months after HIV, hepatitis alert
A Center City Philadelphia dental office is resuming operations two months after a health alert regarding HIV and hepatitis risks.
◼ Archived
Health
🔮 fades
US actions harm global efforts to prevent and treat HIV in dozens of countries, new report says
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
1,700 H.I.V. Treatment Sites Closed After Trump Aid Cuts, a Study Finds
Studies reveal severe domestic and global impacts, including 1,700 site closures, following Trump administration HIV funding cuts.
◼ Archived
Health
🔮 fades
Could GLP-1 Drugs Help You Live Longer?
New research is exploring whether GLP-1 weight loss medications like Ozempic can slow the biological aging process and increase human longevity.
◼ Archived
Health
🔮 fades
‘A matter of life or death’: the activists confronting Congress about slashing HIV funding
Activists are confronting Congress as a proposed $1 billion cut to HIV funding draws widespread criticism and concern over the reversal of prevention progress.
◼ Archived
Health
🔮 fades
Global HIV prevention declined drastically after Trump aid cuts, U.N. finds
Global HIV prevention efforts declined drastically following aid cuts, according to findings from a recent United Nations report.